Misspoke? Maybe he did. But asking multiple questions about ramifications of backdating data which never occurred, and if that hurts our CD12 data, seems like at a minimum of making misleading statements. CD12 data, as I said is irrelevant at the moment. Our Brazil trial protocols are spectacular. They're large 1:1 trials, and don't need the support of CD12 data. If anything CD12 data can bolster our claims of decreasing mortality. But when people are trying to imply that CD12 data is no longer valid, that seems misleading